Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3

Page 1

	Year	Citations
Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation Thais M. Sielecki, John F. Boylan, Pamela A. Benfield, Journal of Medicinal Chemistry Drug TargetAltmetric Attention ScoreCell CyclePre-clinical PharmacologySystems Pharmacology	2000	323
Inhibition of CDKs as a Therapeutic Modality Edward A. Sausville, J I Johnson, Michael C. Alley, Annals of the New York Academy of Sciences Chemoprevention StrategyMedicineReceptor Tyrosine KinaseAnti-cancer AgentPharmacotherapy	2000	81
Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK) Inhibitors David A. Nugiel, Ana-Marie Etzkorn, Anup Vidwans, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryMolecular SciencesDrug TargetBiochemistry	2001	77
Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 2. Probing the Indeno Ring Substituent Pattern David A. Nugiel, Anup Vidwans, Anna-Marie Etzkorn, Journal of Medicinal Chemistry Indenopyrazole-based Cyclin-dependent KinaseChemoprevention StrategyKinase Atp PocketSemicarbazide-based InhibitorsOrganic Chemistry	2002	74
Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 3. Structure Activity Relationships at C3 Eddy W. Yue, C. Anne Higley, Susan V. DiMeo, Journal of Medicinal Chemistry Potent AnaloguesMolecular PharmacologyMedicinal ChemistryCyclin-dependent Kinase InhibitorsCyclin-dependent Kinases	2002	47

Page 1